Company Overview
Prosolia, Inc. is a scientific instrument company engaged in the development, marketing and distribution of innovative sample introduction methods for mass spectrometry and ion mobility systems that address the rapidly evolving needs of diverse customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications. Prosolia's products simplify the analytical workflow and enable scientists in the aforementioned market to:
- Explore where drugs and their metabolites distribute using mass spectrometry imaging.
- Quantify drugs in biological fluids and tissue sections.
- Discover biomarkers of cancer and other diseases in biopsy tissue.
- Identify counterfeit medicines, contaminants in drug and materials manufacturing, pesticides in agricultural products and chemical agents in the field.
In addition to product development, the company provides contract research services to support customer's needs in mass spectrometry.
Mission
Prosolia's mission is to deliver innovative analytical chemistry technologies that expand the use of mass spectrometry to advance scientific knowledge and improve quality of life.